Home Equities Score Why Atossa Therapeutics (ATOS) Is Surging 38% Pre-Market?

Why Atossa Therapeutics (ATOS) Is Surging 38% Pre-Market?

Before the ring of the bell today, Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company, has been seeing a 30.24% jump in its stock price. At the close of the previous session, the stock was up 16.43% to close at $2.48. Over the past 5 sessions, the stock is down -8.49% while the decline increases to -36.25% for the month. The stock has added 125.45% in the past year whereas its year-to-date performance stands at a gain of 161.05%.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

There has been no directly related news to drive that momentum, but the recent developments may also be an indicator of how the company is currently performing.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Recent developments:

Atossa Therapeutics is dedicated to discovering and developing innovative drugs in the oncology and infectious disease fields. At present, the company is focusing its efforts on COVID-19 and breast cancer.

Last month, Atossa Therapeutics announced results from its Phase 1 double-blind, randomized, placebo-controlled clinical study using AT-301, Atossa’s proprietary nasal spray candidate.

  • A total of two different dose levels of AT-301 were tested over a 14-day period in healthy males and females in this study.
  • For newly diagnosed patients with COVID-19, AT-301 is being developed for at-home use.
  • Current FDA-approved treatments to treat COVID-19 cannot be used at home.
  • According to the studies’ final data analysis, no serious adverse events, no discontinuations, no bronchospasms were observed.
  • All subjects but one was observed to have adverse effects, which were found to be moderate in severity whereas all other adverse effects were milder.
  • AT-301 nasal spray was well tolerated in this study and was deemed safe by Atossa.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

  • AT-301 has been associated with nasal discomfort and sneezing as the most common treatment-related adverse events when administered in either a single or multiple doses.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Amarin Corporation plc (NASDAQ: AMRN) stock plunged in the premarket trading session; here’s why

In the premarket trading session, Amarin Corporation plc (AMRN) stock had plunged by -4.56% to $4.4. AMRN stock closed previous session at $4.61 gaining...

Why Second Sight Medical Products, Inc. (EYES) stock is Popping High today?

Second Sight Medical Products, Inc. (EYES) stock announced two-year results of its Orion Study after which the EYES stock price happened to be green...

Luokung Technology Corp. (LKCO) Stock Undergoes Volatility as Appeal Over CCMC Designation is Underway

Luokung Technology Corp. (LKCO) stock prices were down by 6.40% as of the market closing on May 11th, 2021, bringing the price per share...

Vista Gold Corp. (VGZ) Stock Inches Higher After Promising Q1 2021 Financial Reports

Vista Gold Corp. (VGZ) stock prices were up by an incremental 1.82% as of the market closing on May 11th, 2021, bringing the price...

Array Technologies, Inc. (ARRY) Stock Prices Stay Stable Despite Troubling Q1 2021 Financial Reports

Array Technologies, Inc. (ARRY) stock prices were up by a marginal 0.28% as of the market closing on May 11th, 2021, bringing the price...

Lucira Health Inc. (NASDAQ:LHDX) stock rallied today in the current trading session; here’s why

In the current trading session at last check, Lucira Health Inc. (LHDX) shares had surged by 15.32% to the price of $5.87. LHDX's stock...

PaySign, Inc. (PAYS) Stock Down Following Disclosure of Troubling Q1 2021 Financial Reports

PaySign, Inc. (PAYS) stock prices were down 15.0568% early in the trading day on May 12th, 2021, bringing the price per share down to...

Comstock Mining Inc. (NASDAQ:LODE) stock plunged in the current trading session; here’s why

In the current trading session at the last check, Comstock Mining Inc. (LODE) stock had plunged -3.25% to trade at $3.21. LODE stock previously...

Related News

China Automotive Inc. (NASDAQ: CAAS) stock gains during current market. What is happening?

China Automotive Inc. (NASDAQ: CAAS) stock soars by 9.83% during current market trading after CAAS released its first-quarter 2021 financial results. China Automotive Systems...

Urban Tea Inc. (NASDAQ: MYT) stock fell during pre-market trading session. Here’s to know what has happened?

Urban Tea Inc. (NASDAQ: MYT) stock declined by 1.51% at last close whereas the MYT stock price gains by 5.1% in the pre-market trading...

Checkpoint Therapeutics, Inc. (CKPT) Stock Undergoes Volatility after Release of Q1 2021 Financial Reports

Checkpoint Therapeutics, Inc. (CKPT) stock prices were up 4.17% as of the market closing on May 11th, 2021, bringing the price per share up...

Obalon Therapeutics Inc. soared in the recent premarket trading session here’s why

In the premarket trading session, at last check, Obalon Therapeutics Inc. (OBLN) stock had surged by 6.48% to $3.12. OBLN stock previously closed session...

Aslan Pharmaceuticals Inc. (NASDAQ: ASLN) stock declines during pre-market. Here’s what’s happening?

Aslan Pharmaceuticals Inc. (NASDAQ: ASLN) stock plunged by 1.77% at last close while the ASLN stock price keeps falling by 6.12% in the pre-market...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.